Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
A crowded field of next-generation contenders is also pushing forward: Amgen's AMG 133, Roche's GLP-1/GIP co-agonists, AstraZeneca's cotadutide, and Phase 2 candidates like HRS9531 and MariTide (a GLP-1 agonists plus GIP antagonist) are all showing early promise in obesity treatment
Correct coding for intravitreal injections is a complex process
B., Calanna, S., Holst, J
Novos pricing strategy also contributes to its market leadership
Blockade of LAG-3 and PD-1 leads to coexpression of cytotoxic and exhaustion gene modules in CD8(+) T cells to promote antitumor immunity
US$ 21.50
US$ 20.43
US$ 23.20
US$ 25.69
US$ 25.34
US$ 24.28
